Cancer Guardian Structure and Features
Support
Cancer Information Line (Day 1 Benefit)
A member support line staffed by oncology experts who provide guidance for any cancer related topic.
Medical Records Platform (Day 1 Benefit)
A cloud-based platform where members can consolidate their medical records and images for simplified viewing and secure sharing.
Cancer Support Specialist
Following a cancer diagnosis, a Cancer Support Specialist will be assigned to provide dedicated support throughout the cancer journey.
Additionally, Cancer Guardian provides:
- Expert Pathology Review
- On-Site Nurse Advocate (one visit)
DNA Testing
Preventive: Hereditary Risk Screening Test (Day 1 Benefit)
Using a simple saliva sample, this testing evaluates DNA to determine if a member may be at a higher risk for developing cancer, due to a hereditary mutation.
Post Diagnosis: Advanced DNA Testing of the Cancer
Following a cancer diagnosis, members have access to Advanced DNA Testing of their cancer, which can help identify the most effective treatment options available.
Navigation
Members who have been diagnosed with cancer will receive access to expert Navigation Services.
1. Clinical Trial Explorer
The Explorer program uses AI technology and experienced research oncologists to identify clinical trials the member is eligible for.
2. Financial Navigation Report
The Financial Navigation solution draws from a rich ecosystem of over $4 billion of public and private funds to identify financial aid and subsidies the member may qualify for.
Learn about your genes and how they impact your health
with genetic information on your risk for cancer.
Cancer Guardian participants will have access to a Hereditary Genetic Screening Test to better understand their risk for hereditary cancers.
Cancer Guardian makes a significant annual contribution to the American Cancer Society on behalf of our Cancer Guardian members.
What people are saying about Advanced DNA Testing, a part of Cancer Guardian membership, and how it gives them piece of mind for the future.
-
Making Cancer Guardian an integral part of our benefits offering for our own employees, in addition to adding this valuable program to the suite of benefits that we make available to all Keystone clients has been one of the easiest decisions I have made as a CEO.
I think this program could be one of the most personally rewarding things I have ever had the privilege of being a part of in my career. It’s a way to show our employees and our clients how much we care about their well-being.
The WGA team has provided flawless enrollment and administration to our staff and our clients giving us the highest level of confidence in everything they do.
-
Corey had an Advanced DNA Test that determined that she was positive for the mutation ROS-1. This qualified her for targeted therapy, and she was started on the drug, Crizotinib, 3 days later.
As a result, Corey’s cancer went into remission. She takes her precision medicine twice a day, with minimal side-effects, and keeps her cancer in remission. In her own words “I feel like I’m back to the high I was at before, a good place where I could continue my life.”
